Stocks-GSK-GlaxoSmithKline plc ADR

GSK GlaxoSmithKline plc ADR

41.91 0 (0%)
市場休市延遲價格來源為納斯達克, 美元
交易
交易

GlaxoSmithKline plc ADR 價格

3.48% 過去1周
市值
85.04B
日範圍
41.70
-
41.98
52周範圍
33.15
-
42.14
交易量(3個月)
3.27M
市盈率
13.85
收入
37.73B
已置頂的帖子
Cancer Treatment Stocks
Novartis to acquire cancer-focused MorphoSys for $2.9 billion. 💊 Drugmaker $NVS (Novartis ADR) said it will acquire $MOR.DE (MorphoSys), a developer of cancer treatments, for €2.7 billion, adding a promising rare bone-marrow cancer treatment candidate to its portfolio. German biotech firm's shares... 顯示更多 翻譯
點讚 評論分享
顯示更多評論3的2
null
.
熱門討論

分析師預測

共識
持有
價格目標
45.00

人們還購買